Immunologic changes point to potential for clinical investigation of combination immunotherapy for deadly kidney cancer – Medical Xpress
|
Immunologic changes point to potential for clinical investigation of combination immunotherapy for deadly kidney cancer
Medical Xpress Immunologic changes observed in an early study of patients with metastatic renal cell carcinoma (MRCC) raised the possibility for a larger clinical study of combination immunotherapy, according to findings reported by researchers at The University of … |
